We are Sorry, This Page doesn't Exist

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) disclosed Tuesday that its antibody cocktail showed positive results in early-stage trials for hospitalized patients. read more.....»»

Supernus Pharmaceuticals Inc. shares jumped more than 20% in after-hours trading Tuesday after the company revealed positive .....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Shares of Veru Inc. soared 51.4% toward a seven-year high on massive volume, after the biopharmaceutical company announced positive results from a Phase 2 study of its treatment.....»»

Shares of CymaBay Therapeutics Inc. rocketed on in very active morning trading Tuesday, after an upbeat report on results of a study of its treatme.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

In a matter of weeks, remdesivir has gone from a shelved, failed hepatitis C treatment to the center of a national effort to treat patients suffering from covid-19, the illness caused by the novel coronavirus......»»

In a matter of weeks, remdesivir has gone from a shelved, failed hepatitis C treatment to the center of a national effort to treat patients suffering from covid-19, the illness caused by the novel coronavirus......»»

STOCKHOLM, May 7, 2020 /PRNewswire/ -- FDA and EMA endorse the advancement of cobitolimod into phase III studies "The positive responses from the regulators is an important external validation of our study results and cobitolimod's po.....»»

Amgen Inc on Thursday reported better-than-expected first-quarter results and said it plans to study psoriasis drug Otezla as a potential treatment for COVID-19, the respiratory disease caused by the new coronavirus......»»

Amgen Inc on Thursday reported better-than-expected first-quarter results on Thursday and said it plans to study psoriasis drug Otezla as a potential treatment for COVID-19, the respiratory disease caused by the new coronavirus......»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Highlights: Strong cash position with reserves of AUD $4.09M Formalized a Phase I Clinical trial agreement to conduct a first-in-human study of RECCE® 327 Completed successful in-vivo toxicity st.....»»

Gainers Capricor Therapeutics, Inc. (NASDAQ: CAPR) shares climbed 138.2% to $5.74 after the company reported that its new data from study of 6 critically-ill coronavirus patients showed 100% survival following treatment with its CAP-1002. read more.....»»

A study showed positive results on using a Gilead Sciences drug as a COVID-19 treatment; the government will offer more details at an upcoming briefing......»»

REUTERS/Tobias Schwarz Researchers are narrowing the focus of an ongoing trial of a potential coronavirus treatment after reviewing preliminary results.....»»

Associated Press.....»»

Rates of death in the groups treated with the drugs were worse than for those who received no treatment, and rates of patients on ventilators were similar, the study found......»»